306 related articles for article (PubMed ID: 30886205)
21. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.
Jung J; Jung Y; Bang EJ; Cho SI; Jang YJ; Kwak JM; Ryu DH; Park S; Hwang GS
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S736-42. PubMed ID: 25092158
[TBL] [Abstract][Full Text] [Related]
22. A novel faecal
Liang JQ; Li T; Nakatsu G; Chen YX; Yau TO; Chu E; Wong S; Szeto CH; Ng SC; Chan FKL; Fang JY; Sung JJY; Yu J
Gut; 2020 Jul; 69(7):1248-1257. PubMed ID: 31776231
[TBL] [Abstract][Full Text] [Related]
23. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
24.
Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
[TBL] [Abstract][Full Text] [Related]
25. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic yield of advanced colorectal neoplasia at colonoscopy, according to indications: an investigation from the Korean Association for the Study of Intestinal Diseases (KASID).
Park DI; Kim YH; Kim HS; Kim WH; Kim TI; Kim HJ; Yang SK; Byeon JS; Lee MS; Jung IK; Chung MK; Jung SA; Jeen YT; Choi JH; Choi H; Han DS; Song JS
Endoscopy; 2006 May; 38(5):449-55. PubMed ID: 16767578
[TBL] [Abstract][Full Text] [Related]
27. Low- and high-grade bladder cancer determination via human serum-based metabolomics approach.
Bansal N; Gupta A; Mitash N; Shakya PS; Mandhani A; Mahdi AA; Sankhwar SN; Mandal SK
J Proteome Res; 2013 Dec; 12(12):5839-50. PubMed ID: 24219689
[TBL] [Abstract][Full Text] [Related]
28. An integrative approach based on GC-qMS and NMR metabolomics data as a comprehensive strategy to search potential breast cancer biomarkers.
Silva CL; Perestrelo R; Capelinha F; Tomás H; Câmara JS
Metabolomics; 2021 Aug; 17(8):72. PubMed ID: 34389918
[TBL] [Abstract][Full Text] [Related]
29. Tissue amino acid profile could be used to differentiate advanced adenoma from colorectal cancer.
Gao P; Zhou C; Zhao L; Zhang G; Zhang Y
J Pharm Biomed Anal; 2016 Jan; 118():349-355. PubMed ID: 26595283
[TBL] [Abstract][Full Text] [Related]
30. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of synchronous colorectal neoplasms in surgically treated gastric cancer patients and significance of screening colonoscopy.
Suzuki A; Koide N; Takeuchi D; Okumura M; Ishizone S; Suga T; Miyagawa S
Dig Endosc; 2014 May; 26(3):396-402. PubMed ID: 23967873
[TBL] [Abstract][Full Text] [Related]
32. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
33. Revealing the metabonomic variation of EC using ¹H-NMR spectroscopy and its association with the clinicopathological characteristics.
Hasim A; Ma H; Mamtimin B; Abudula A; Niyaz M; Zhang LW; Anwer J; Sheyhidin I
Mol Biol Rep; 2012 Sep; 39(9):8955-64. PubMed ID: 22736106
[TBL] [Abstract][Full Text] [Related]
34. Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia.
Kim NH; Lee MY; Park JH; Park DI; Sohn CI; Choi K; Jung YS
Yonsei Med J; 2017 Sep; 58(5):918-924. PubMed ID: 28792134
[TBL] [Abstract][Full Text] [Related]
35. The
Rådjursöga M; Lindqvist HM; Pedersen A; Karlsson GB; Malmodin D; Brunius C; Ellegård L; Winkvist A
Nutr J; 2019 Apr; 18(1):25. PubMed ID: 30961592
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
[TBL] [Abstract][Full Text] [Related]
37. Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma.
Wang H; Zhang B; Li X; Zhou D; Li Y; Jia S; Qi S; Xu A; Zhao X; Wang J; Bai Z; Cao B; Li N; Dai M; Chen H; Huang J
Front Oncol; 2020; 10():1081. PubMed ID: 32793472
[No Abstract] [Full Text] [Related]
38. Urinary charged metabolite profiling of colorectal cancer using capillary electrophoresis-mass spectrometry.
Udo R; Katsumata K; Kuwabara H; Enomoto M; Ishizaki T; Sunamura M; Nagakawa Y; Soya R; Sugimoto M; Tsuchida A
Sci Rep; 2020 Dec; 10(1):21057. PubMed ID: 33273632
[TBL] [Abstract][Full Text] [Related]
39. Urinary metabolomics in newborns infected by human cytomegalovirus: a preliminary investigation.
Fanos V; Locci E; Noto A; Lazzarotto T; Manzoni P; Atzori L; Lanari M
Early Hum Dev; 2013 Jun; 89 Suppl 1():S58-61. PubMed ID: 23809353
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
